1-3 of 3
Rodrigo Carlini Fernando
Close
Sort by
Journal Articles

In Vitro JAK1/2 Inhibition, in Association with Bortezomib and Lenalidomide, Is Comparable with Bortezomib, Lenalidomide and Dexametasone: An Alternative for Multiple Myeloma Patients with JAK2 overexpression?

Mariana Bleker de Oliveira, BSc, Veruska Lia Fook Alves, PhD, Angela Isabel Eugenio, BSc, Rodrigo Carlini Fernando, BSc, Mihoko Yamamoto, MD PhD, Gisele W. B. Colleoni, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5663.
https://doi.org/10.1182/blood.V128.22.5663.5663
Published: 2016
Journal Articles

Multiple Myeloma Cancer Stem Cells: Immunophenotypic and Functional Characterization, Gene Expression Profiling and Therapeutic Targets

Mariana Bleker de Oliveira, BSc, Paola Marino Dantonio, BSc, Veruska Lia Fook Alves, PhD, Rodrigo Carlini Fernando, BSc, Daniela Teixeira, MSc, Alexandre Basso, PhD, Mihoko Yamamoto, MD PhD, Gisele W. B. Colleoni, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4434.
https://doi.org/10.1182/blood.V128.22.4434.4434
Published: 2016
Journal Articles

Serum Free Light Chain Is Not a Good Biomarker to Predict Post-Transplant Lymphoprolipherative Disorder Development in Renal Transplanted Patients

Rodrigo Carlini Fernando, Edgar Gil Rizzatti, Walter Moises Tobias Braga, M.D., Melina Gonçalves Santos, Mariana Bleker Oliveira, José Osmar Medina Pestana, Otávio Cesar Carvalho Guimarães Baiocchi, M. D, PhD, Gisele Wally Braga Colleoni
Journal: Blood
Blood (2012) 120 (21): 5079.
https://doi.org/10.1182/blood.V120.21.5079.5079
Published: 2012